About us
Our Story
Leadership
Board of Directors
Scientific Advisory Board
Our Products
Sibnayal®
Other Products
R&D
Disease Focus Area
Distal Renal Tubular Acidosis (dRTA)
Cystinuria
Investors
Investor Relations
Management Team
Press Releases
Events & Presentations
Analyst Coverage
Stock Information
Financial Information
Investors FAQs
Contact Us
EN
FR
Advicenne France
About us
Our Story
Leadership
Board of Directors
Scientific Advisory Board
Our Products
Sibnayal®
Other Products
R&D
Disease Focus Area
Distal Renal Tubular Acidosis (dRTA)
Cystinuria
Investors
Investor Relations
Management Team
Press Releases
Events & Presentations
Analyst Coverage
Stock Information
Financial Information
Investors FAQs
Contact Us
EN
FR
Advicenne France
Nous connaître
Qui sommes-nous ?
L’équipe de direction
Le conseil d’administration
Le conseil scientifique
Nos produits
Sibnayal®
Autres produits
R&D
Pathologies ciblées
Acidose Tubulaire Rénale distale (ATRd)
Cystinurie
Investisseurs
Relations Investisseurs
Équipe de direction
Communiqués de Presse
Événements & Présentations
Analystes
Action Advicenne
Information Financière
FAQ Investisseurs
Contact
EN
FR
Site France
Financial Information
Investor Relations
Management Team
Letter from the CEO
Management
Board of Directors – Gouvernance
Governance
Press Releases
Events & Presentations
Analyst Coverage
Stock Information
Financial Information
Investors FAQs
Relations Investisseurs
Équipe de direction
Message du DG
Équipe de Direction
Conseil d’Administration
Gouvernance
Communiqués de presse
Événements & présentations
Analystes
L’action Advicenne
Information Financière
FAQ Investisseurs
Materials for Annual Shareholders Meeting
SHAREHOLDERS MEETING FILES ARE AVAILABLE ONLY IN FRENCH
Regulated Informations
All
2017
2018
2019
2020
2022
2023
2024
April 5, 2024 -
2023 Universal Registration Document
April 28, 2023 -
2022 Universal Registration Document
January 3, 2023 -
Bilan semestriel S2 du contrat de liquidité contracté avec la Société de Bourse Gilbert Dupont Paris
September 21, 2022 -
Half year financial report 2022 and auditors’ report
July 1, 2022 -
Bilan semestriel S1 du contrat de liquidité contracté avec la Société de Bourse Gilbert Dupont
June 9, 2022 -
Share-purchase program authorized by the Annual General Meeting of June 9, 2022
April 29, 2022 -
Document d’Enregistrement Universel 2021
October 7, 2020 -
Interim financial report 2020
September 28, 2020 -
Financial Annual Report 2019
September 28, 2020 -
Financial Statements IFRS 2019
September 27, 2019 -
Interim financial report – June 2019
June 11, 2019 -
Annexe IFRS 2018
June 11, 2019 -
Financial Annual Report 2018
September 27, 2018 -
Interim Financial Report – June 2018
November 20, 2017 -
Preliminary International Offering Memorandum
November 2, 2017 -
Document de base (IOM)
